Doxycycline-induced cholestatic liver injury

Clin J Gastroenterol. 2021 Oct;14(5):1503-1510. doi: 10.1007/s12328-021-01475-7. Epub 2021 Jul 6.

Abstract

Doxycycline-induced liver injury is a rare phenomenon, with an unclear clinical course and etiopathogenesis. The onset of injury may be acute-to-subacute, with a pattern ranging from hepatocellular or cholestatic to mixed, and it often lasts up to several weeks. We present a case of cholestatic liver injury secondary to doxycycline use in a middle-aged woman. In patients with a history of doxycycline exposure and subsequent hepatic injury, an adverse drug reaction due to doxycycline should remain on the differential, and immediate removal of the offending agent with close monitoring of the clinical condition should be pursued.

Keywords: Cholestasis; Doxycycline; Drug reaction; Liver injury.

Publication types

  • Case Reports

MeSH terms

  • Chemical and Drug Induced Liver Injury* / diagnosis
  • Chemical and Drug Induced Liver Injury* / etiology
  • Cholestasis* / chemically induced
  • Doxycycline / adverse effects
  • Female
  • Humans
  • Liver
  • Middle Aged

Substances

  • Doxycycline